A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805)QING ZHOU; ZHOU, Cai-Cun; ZHANG, Xu-Chao et al.Lung cancer. 2014, Vol 83, Num 3, pp 369-373, issn 0169-5002, 5 p.Article

A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): Paclitaxel plus carboplatin versus vinorelbine plus cisplatinWON JIN CHANG; SUN, Jong-Mu; JI YEAN LEE et al.Lung cancer. 2014, Vol 84, Num 1, pp 51-55, issn 0169-5002, 5 p.Article

AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell linesPUGLISI, M; THAVASU, P; STEWART, A et al.Lung cancer. 2014, Vol 85, Num 2, pp 141-146, issn 0169-5002, 6 p.Article

Activation of Akt involves resistance to NF-_κB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cellsTOGANO, Tomiteru; WATANABE, Mariko; ITOH, Kinji et al.Lung cancer. 2014, Vol 83, Num 2, pp 139-145, issn 0169-5002, 7 p.Article

Adenocarcinoma arising in an extralobar sequestration: a case report and review of the literatureBELCHIS, Deborah; COWAN, Morgan; MORTMAN, Keith et al.Lung cancer. 2014, Vol 84, Num 1, pp 92-95, issn 0169-5002, 4 p.Article

Aprepitant in patients with advanced non-small-cell lung cancer receiving carboplatin-based chemotherapyITO, Yasuhiro; KARAYAMA, Masato; YAMADA, Takashi et al.Lung cancer. 2014, Vol 84, Num 3, pp 259-264, issn 0169-5002, 6 p.Article

Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangementFUJIWARA, Ayako; HIGASHIYAMA, Masahiko; KANOU, Takashi et al.Lung cancer. 2014, Vol 83, Num 2, pp 302-304, issn 0169-5002, 3 p.Article

CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutationSUDA, Kenichi; MIZUUCHI, Hiroshi; MITSUDOMI, Tetsuya et al.Lung cancer. 2014, Vol 85, Num 2, pp 147-151, issn 0169-5002, 5 p.Article

Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancerGO, Se-Il; LEE, Anna; UN SEOK LEE et al.Lung cancer. 2014, Vol 84, Num 1, pp 79-85, issn 0169-5002, 7 p.Article

DISRUPT: A randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane―platinum regimen as first-line therapy for metastatic non-small cell lung cancerVON PAWEL, Joachim; GORBOUNOVA, Vera; RECK, Martin et al.Lung cancer. 2014, Vol 85, Num 2, pp 224-229, issn 0169-5002, 6 p.Article

EGFR-mutated lung cancer in Li-Fraumeni syndromeMICHALAREA, Vasiliki; CALCASOLA, Matthew; CANE, Paul et al.Lung cancer. 2014, Vol 85, Num 3, pp 485-487, issn 0169-5002, 3 p.Article

Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohortROBINSON, Cleo; ALFONSO, Helman; SAMANTHA WOO et al.Lung cancer. 2014, Vol 86, Num 1, pp 29-34, issn 0169-5002, 6 p.Article

Gender susceptibility for cigarette smoking-attributable lung cancer: A systematic review and meta-analysisYUNXIAN YU; HUI LIU; KEJING YING et al.Lung cancer. 2014, Vol 85, Num 3, pp 351-360, issn 0169-5002, 10 p.Article

Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: A registry studyRASMUSSEN, Jakob F; SIERSMA, Volkert; PEDERSEN, Jesper H et al.Lung cancer. 2014, Vol 83, Num 3, pp 347-355, issn 0169-5002, 9 p.Article

How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?BAYMAN, Neil; BLACKHALL, Fiona; McCLOSKEY, Paula et al.Lung cancer. 2014, Vol 83, Num 2, pp 117-125, issn 0169-5002, 9 p.Article

Identification of mRNAs and lincRNAs associated with lung cancer progression using next-generation RNA sequencing from laser micro-dissected archival FFPE tissue specimensMORTON, Matthew L; XIAODONG BAI; MERRY, Callie R et al.Lung cancer. 2014, Vol 85, Num 1, pp 31-39, issn 0169-5002, 9 p.Article

Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patientsKUIPER, J. L; HEIDEMAN, D. A. M; THUNNISSEN, E et al.Lung cancer. 2014, Vol 85, Num 1, pp 19-24, issn 0169-5002, 6 p.Article

Is ¹⁸F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysisTREGLIA, Giorgio; SADEGHI, Ramin; GIOVANELLA, Luca et al.Lung cancer. 2014, Vol 86, Num 1, pp 5-13, issn 0169-5002, 9 p.Article

Latent TB infection in newly diagnosed lung cancer patients ― A multicenter prospective observational studyFAN, Wen-Chien; TING, Wen-Ying; WU, Ming-Fang et al.Lung cancer. 2014, Vol 85, Num 3, pp 472-478, issn 0169-5002, 7 p.Article

Lung cancer incidence in Singapore: Ethnic and gender differencesLIM, Wei-Yen; CHUEN SENG TAN; EN YUN LOY et al.Lung cancer. 2014, Vol 84, Num 1, pp 23-30, issn 0169-5002, 8 p.Article

MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancerBING LI; SHENGXIANG REN; GUANGHUI GAO et al.Lung cancer. 2014, Vol 83, Num 2, pp 146-153, issn 0169-5002, 8 p.Article

MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cellsCHAI SAN HO; SEOW HUI YAP; NEOH HUN PHUAH et al.Lung cancer. 2014, Vol 83, Num 2, pp 154-162, issn 0169-5002, 9 p.Article

Molecular testing in oncology: Problems, pitfalls and progressO'BRIEN, Cathal P; TAYLOR, Sarah E; O'LEARY, John J et al.Lung cancer. 2014, Vol 83, Num 3, pp 309-315, issn 0169-5002, 7 p.Article

Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial)KOCHER, F; PIRCHER, A; GREIL, R et al.Lung cancer. 2014, Vol 85, Num 3, pp 395-400, issn 0169-5002, 6 p.Article

Pollution in the working place and social status: Co-factors in lung cancer carcinogenesisRAJER, Mirjana; ZWITTER, Matjaz; RAJER, Borut et al.Lung cancer. 2014, Vol 85, Num 3, pp 346-350, issn 0169-5002, 5 p.Article